208 related articles for article (PubMed ID: 7312702)
1. The histology of fibrocystic disease of the female breast. Correlation with epithelial proliferative lesions and carcinoma in situ.
Anastassiades OT; Tsakraklides E; Gogas J
Pathol Res Pract; 1981 Jul; 172(1-2):109-29. PubMed ID: 7312702
[No Abstract] [Full Text] [Related]
2. Sounding board. Fibrocystic "disease" of the breast--a nondisease?
Love SM; Gelman RS; Silen W
N Engl J Med; 1982 Oct; 307(16):1010-4. PubMed ID: 7110289
[No Abstract] [Full Text] [Related]
3. [Fibrocystic disease of the breast: a precancerous condition?].
Goovaerts G; Schüler G; Genton CY
Schweiz Med Wochenschr; 1983 Feb; 113(6):211-7. PubMed ID: 6836248
[No Abstract] [Full Text] [Related]
4. The histopathology of non-palpable breast lesions detected by clinical mammography.
Skjørten FJ; Skaane P; Jacobsen U; Kaaresen R; Haaheim LL
Eur J Surg Oncol; 1990 Dec; 16(6):475-80. PubMed ID: 2253791
[TBL] [Abstract][Full Text] [Related]
5. Pathologic considerations in the high-risk breast patient.
Simmons R; Serafin D; McCarty K
Clin Plast Surg; 1988 Oct; 15(4):655-65. PubMed ID: 2852084
[TBL] [Abstract][Full Text] [Related]
6. Evidence for premalignant lesions in the human breast.
Sloane JP
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():17-21. PubMed ID: 8298446
[No Abstract] [Full Text] [Related]
7. [Significance of hyperelastosis in proliferative lesions of the breast].
Cuccurullo L; Giordano GG; Mineo A; Iaccarino M; Battista O; Cattaneo L; Ferraraccio F
Pathologica; 1984; 76(1041):89-101. PubMed ID: 6087264
[No Abstract] [Full Text] [Related]
8. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
Böcker W; Jarasch ED; Nagle EB; Höhne R
Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
[No Abstract] [Full Text] [Related]
9. Core biopsy of nodular adenosis of the breast can lead to underdiagnosis.
Westenend PJ; Liem SJ
AJR Am J Roentgenol; 2001 Jun; 176(6):1596. PubMed ID: 11373239
[No Abstract] [Full Text] [Related]
10. [Benign and premalignant breast lesions--clinico-pathological correlation].
Afek A; Shibi R; Kopolovitz G
Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
[No Abstract] [Full Text] [Related]
11. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
Sahoo S; Recant WM
Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
[TBL] [Abstract][Full Text] [Related]
12. The myoepithelial cell in lesions of the breast: a review.
Flinner RL; Hammond EH
Pathol Annu; 1993; 28 Pt 2():145-69. PubMed ID: 8395043
[No Abstract] [Full Text] [Related]
13. [Clinico-pathological study of fibrocystic disease of the breast. Analysis of 186 cases].
Martínez Cárdenas S; Guerra Medina J
Ginecol Obstet Mex; 1980 Dec; 48(290):409-24. PubMed ID: 7262580
[No Abstract] [Full Text] [Related]
14. [Benign lesions of the mammary gland presenting as cancer. Patholo-anatomic aspects].
Rüttner JR
Gynakol Rundsch; 1981; 21 Suppl 1():22-32. PubMed ID: 7239338
[No Abstract] [Full Text] [Related]
15. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
16. [Needle aspiration cytologic examinations of dysplastic diseases of the breast (mastopathy, adenosis, ductasia and gynecomastia].
Degrell I
Pathologe; 1982 Jul; 3(4):198-202. PubMed ID: 6125937
[No Abstract] [Full Text] [Related]
17. [Biopsy of breast microcalcifications using an 11-Gauge vacuum-assisted device: roles and challenges for the pathologist].
Becette V; Chérel P; Menet E; Yacoub S; Brain E; Hagay C; Guinebretière JM
Ann Pathol; 2003 Dec; 23(6):496-507. PubMed ID: 15094588
[TBL] [Abstract][Full Text] [Related]
18. [Value of cytology for diagnosis of breast cancer].
Tessmann D; Pommerenke F
Z Arztl Fortbild (Jena); 1990; 84(14):719-21. PubMed ID: 2176017
[No Abstract] [Full Text] [Related]
19. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
Shirley SE
West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
[TBL] [Abstract][Full Text] [Related]
20. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
Contesso G
J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
